In addition, lung fibrosis was alleviated by PFD through inhibiting profibrotic signalling pathways, including transformation growth factor‐β1 (TGF‐β1)/Smad3 pathway and mitogen‐activated protein kinase (MAPK) pathway.8, 11. The gene discussed is SMAD3; the disease is pulmonary fibrosis.